Back to all fonts

WhatFontIs All fonts

Vaccine Bold Italic

Adobe

fontPreviewfontPreviewfontPreviewfontPreviewfontPreviewfontPreview

Vaccine Bold Italic

2.83/5

1920 votes, rated based on results identification

Publisher

Adobe

License

Commercial

Date added

Dec 01 2020

Description

Bold italic serif font with a classic and elegant style. This font features a bold and italic style with a classic serif design. The characters have a slight slant, adding a dynamic and elegant touch. The strokes are consistent and well-defined, providing a strong visual presence.
Ideal for book covers, formal invitations, and branding materials that require a touch of elegance.
Headlines, Logos, Branding
Balanced
Download Vaccine Bold Italic font. Vaccine Bold Italic by Adobe Systems Incorporated. All rights reserved.

See the font with your own text

Vaccine Bold Italic

Category

Serif

Italic

Yes

Width

Normal

Line height

Normal

Overall style

Classic

Cap height

High

Bold

Yes

Weight

Bold

Character spacing

Normal

Contrast

Medium

X height

Medium

Proposed projects

Ideal for book covers, formal invitations, and branding materials that require a touch of elegance.

Use case

Headlines, Logos, Branding

Ascender descender ratio

Balanced

Similar Free Fonts for Vaccine Bold Italic

Bitter Bold Italic

Free for personal use

Radcliffe Display Italic

Free for personal use

Similar Fonts for Vaccine Bold Italic from Adobe.com

Vaccine Bold Italic

$ Commercial > Adobe.com

Vaccine Extra Bold Italic

$ Commercial > Adobe.com

Similar Fonts for Vaccine Bold Italic from MyFonts.com

Vaccine Bold Italic

$ Commercial > MyFonts.com

Vaccine Italic

$ Commercial > MyFonts.com

Similar Fonts for Vaccine Bold Italic from CreativeMarket.com

Testun Italic otf (400)

$ Commercial > CreativeMarket.com

Radcliffe Hand otf (700)

$ Commercial > CreativeMarket.com

Latest from the forum

forumPostPreview

Maybe or unanswered

suebooks
7 hours ago
0 replies (7 hours ago)
forumPostPreview

Maybe or unanswered

14
9 hours ago
1 reply (5 hours ago)